A deep learning model is presented for deconvoluting molecular expression from low-plex immunofluorescence imaging, paves the way for clinically implementable TIME stratification based on low-plex immunofluorescence images, and allows for standard single-cell analysis workflows to interpret multicellular expression data from regions of interest.
Abstract
Spatial omics allows for comprehensive investigation of the tumor immune microenvironment (TIME). Stratifying patients by their TIMEs contributes with insights in tumor immune response and has the potential to guide treatment decision-making in the immuno-oncology setting. However, high-plex spatial omics approaches still suffer from high costs and limited direct clinical applicability. We address this issue by presenting a deep learning model, Image2Count, for deconvoluting molecular expression from low-plex immunofluorescence imaging. Explicitly, our model learns visual representations of cells in a contrastive manner, utilizing Graph Neural Networks to predict expressions from cell graphs, enabling the trained model to predict high-plex single-cell expression from just four marker images. We measure model performance using an ovarian cancer GeoMx dataset with “bulk” Region of Interest 72-plex protein counts, a Cyclic IF (t-CyCIF) 25-plex single-cell resolution colorectal cancer dataset, and a 960-plex RNA single-cell resolution CosMx non-small cell lung cancer dataset. Image2Count is able to predict distinct spatial expression patterns of subsets of tumor, immune and stromal cells, and displays a generally improved accuracy when considering neighborhoods of cells over single cells. Concordance of pathways enriched in true and predicted data indicates the ability to capture biologically relevant information. Our model paves the way for clinically implementable TIME stratification based on low-plex immunofluorescence images, and allows for standard single-cell analysis workflows to interpret multicellular expression data from regions of interest.
This work developed and clinically validated the System for Enhanced Evaluation of Tumor Cells (SEE-TC), a deep learning approach for scalable, reproducible phenotyping of individual circulating cells that is the first fully automated AI approach to single-cell segmentation and CTC phenotyping.
M. Bootsma, M. Sharifi, J. Sperger et al.· Clinical Cancer Research· 0 citations
GITIII-scale is presented, a hierarchical, interpretable pan-cancer spatial transcriptomics foundation model for TME representation learning that investigates cell state-niche associations and their underlying ligand-receptor (LR) signaling pathways that recovered niche-associated state changes more accurately than exi...
Xiaohui Xiao, Jia-Shu He, Shiyang Zhang et al.· 0 citations
Significance Rare-cell identification in fluorescence microscopy remains challenging because targets are sparse and background varies between specimens. Combining specimen-specific fluorescence enrichment with image classification may enable efficient and more specific automated detection of rare cells. Aim We develope...
Cody C. Rounds, Divya Ravi, Ge Huang et al.· bioRxiv· 0 citations
Simple Summary Cancer treatment is often complicated by the fact that tumor tissues are not uniform. Different cells occupy distinct locations, communicate with nearby cells, and respond differently to treatment. Spatial multi-omics provides a way to examine these differences while preserving information about where bi...
Pancreatic ductal adenocarcinoma (PDAC) remains among the most lethal solid tumors, and it is defined less by any single driver mutation than by its architecture: a dense desmoplastic stroma, a spatially organized immunosuppressive microenvironment, and profound intratumoral heterogeneity. Bulk profiling and manual h...
J. Park· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.